SynthesisBMC cardiovascular disorders2026
Heart rate variability as a dual-use digital biomarker: integrating clinical, AI, and operational perspectives on human performance and resilience.
Synthesis in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHeart rate variability (HRV) reflects autonomic regulation and has emerged as a dual-use digital biomarker across clinical care and operational performance. We sought to integrate evidence on HRV’s physiological basis, clinical utility, defense applications, and AI-enabled analytics, and to propose a cross-sector framework for predictive, ethical deployment.
methodsWe conducted a structured literature review in MEDLINE (PubMed), Embase, and Scopus between July 1st and August 31st, 2025, without language restriction. Eligible studies reported human HRV parameters measured in clinical, operational/defense, or AI contexts. Owing to heterogeneity, findings were summarized narratively across five domains: physiology, clinical applications, operational use, AI/predictive analytics, and ethics/standardization.
resultsEvidence from military and operational studies supports HRV as a physiological indicator of stress accumulation, fatigue, and recovery during sustained workload and mission exposure. Across training environments, continuous HRV monitoring captured early autonomic changes preceding measurable performance decline or clinical symptoms. During prolonged field exercises, nocturnal HRV reductions consistently reflected accumulated allostatic load, while daily fluctuations in SDNN, RMSSD, and LF/HF ratios revealed real-time adaptations to physical exertion, sleep deprivation, and psychological strain. These dynamic shifts offered a quantifiable index of resilience, distinguishing between individuals able to sustain operational effectiveness and those approaching physiological or cognitive exhaustion. AI further enhances this capability by identifying non-linear and context-dependent HRV patterns that precede fatigue or decompensation. Machine-learning models trained on multimodal data streams enable early detection of autonomic instability and predictive risk stratification in both training and operational theaters.
conclusionsHRV is not just a number—it is a real-time window into how our bodies respond to life’s challenges, from the doctor’s office to the most demanding missions. What makes HRV so unique is its “dual-use” quality: it matters just as much for medical professionals caring for patients as it does for those monitoring the wellbeing and performance of people working under stress, such as soldiers or first responders. By treating HRV as a dual-use tool, one can bridge the worlds of healthcare and operational performance. This means the same heartbeat data that helps predict heart problems for a patient can also warn a team leader when their crew might be on the edge of exhaustion. But making the most of HRV in both settings requires to collect data consistently, analyze it with trustworthy AI, protect privacy, and put clear guidelines in place. In doing so, HRV becomes more than a monitor—a practical, ethical way to support better decisions, whether saving lives in a hospital or keeping people safe and effective under pressure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.